15-72735137-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033028.5(BBS4):​c.1061T>C​(p.Ile354Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.605 in 1,612,062 control chromosomes in the GnomAD database, including 303,685 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 23091 hom., cov: 32)
Exomes 𝑓: 0.61 ( 280594 hom. )

Consequence

BBS4
NM_033028.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.248

Publications

56 publications found
Variant links:
Genes affected
BBS4 (HGNC:969): (Bardet-Biedl syndrome 4) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene has sequence similarity to O-linked N-acetylglucosamine (O-GlcNAc) transferases in plants and archaebacteria and in human forms a multi-protein "BBSome" complex with seven other BBS proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
BBS4 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.0739299E-6).
BP6
Variant 15-72735137-T-C is Benign according to our data. Variant chr15-72735137-T-C is described in ClinVar as Benign. ClinVar VariationId is 21734.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.638 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS4NM_033028.5 linkc.1061T>C p.Ile354Thr missense_variant Exon 13 of 16 ENST00000268057.9 NP_149017.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS4ENST00000268057.9 linkc.1061T>C p.Ile354Thr missense_variant Exon 13 of 16 1 NM_033028.5 ENSP00000268057.4

Frequencies

GnomAD3 genomes
AF:
0.527
AC:
80060
AN:
151870
Hom.:
23108
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.311
Gnomad AMI
AF:
0.697
Gnomad AMR
AF:
0.531
Gnomad ASJ
AF:
0.673
Gnomad EAS
AF:
0.244
Gnomad SAS
AF:
0.586
Gnomad FIN
AF:
0.658
Gnomad MID
AF:
0.694
Gnomad NFE
AF:
0.644
Gnomad OTH
AF:
0.555
GnomAD2 exomes
AF:
0.573
AC:
144029
AN:
251154
AF XY:
0.587
show subpopulations
Gnomad AFR exome
AF:
0.306
Gnomad AMR exome
AF:
0.497
Gnomad ASJ exome
AF:
0.674
Gnomad EAS exome
AF:
0.248
Gnomad FIN exome
AF:
0.662
Gnomad NFE exome
AF:
0.652
Gnomad OTH exome
AF:
0.609
GnomAD4 exome
AF:
0.613
AC:
895113
AN:
1460074
Hom.:
280594
Cov.:
37
AF XY:
0.616
AC XY:
447589
AN XY:
726432
show subpopulations
African (AFR)
AF:
0.307
AC:
10266
AN:
33462
American (AMR)
AF:
0.497
AC:
22232
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.675
AC:
17620
AN:
26114
East Asian (EAS)
AF:
0.229
AC:
9095
AN:
39684
South Asian (SAS)
AF:
0.601
AC:
51796
AN:
86226
European-Finnish (FIN)
AF:
0.662
AC:
35322
AN:
53378
Middle Eastern (MID)
AF:
0.632
AC:
3594
AN:
5690
European-Non Finnish (NFE)
AF:
0.639
AC:
709763
AN:
1110494
Other (OTH)
AF:
0.587
AC:
35425
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
17880
35760
53640
71520
89400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18542
37084
55626
74168
92710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.527
AC:
80052
AN:
151988
Hom.:
23091
Cov.:
32
AF XY:
0.530
AC XY:
39337
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.311
AC:
12893
AN:
41468
American (AMR)
AF:
0.530
AC:
8095
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.673
AC:
2330
AN:
3462
East Asian (EAS)
AF:
0.245
AC:
1268
AN:
5170
South Asian (SAS)
AF:
0.585
AC:
2817
AN:
4814
European-Finnish (FIN)
AF:
0.658
AC:
6934
AN:
10540
Middle Eastern (MID)
AF:
0.682
AC:
199
AN:
292
European-Non Finnish (NFE)
AF:
0.644
AC:
43723
AN:
67944
Other (OTH)
AF:
0.549
AC:
1159
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1746
3492
5238
6984
8730
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
696
1392
2088
2784
3480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.600
Hom.:
109140
Bravo
AF:
0.508
TwinsUK
AF:
0.642
AC:
2382
ALSPAC
AF:
0.648
AC:
2497
ESP6500AA
AF:
0.322
AC:
1416
ESP6500EA
AF:
0.640
AC:
5504
ExAC
AF:
0.573
AC:
69585
Asia WGS
AF:
0.395
AC:
1378
AN:
3478
EpiCase
AF:
0.647
EpiControl
AF:
0.653

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 17, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Bardet-Biedl syndrome 4 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Bardet-Biedl syndrome Benign:2
Oct 13, 2009
GeneReviews
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 1 Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
8.3
DANN
Benign
0.66
DEOGEN2
Benign
0.23
.;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.045
N
LIST_S2
Benign
0.12
T;T
MetaRNN
Benign
0.0000021
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.0
.;N
PhyloP100
-0.25
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.19
.;N
REVEL
Benign
0.19
Sift
Benign
0.40
.;T
Sift4G
Benign
0.40
T;T
Polyphen
0.0
.;B
Vest4
0.066
MPC
0.012
ClinPred
0.0091
T
GERP RS
-4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.063
gMVP
0.15
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2277598; hg19: chr15-73027478; COSMIC: COSV51438920; COSMIC: COSV51438920; API